http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107412192-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44ae178fe5ea1fd193b8e5e1baf1ab3b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0002
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
filingDate 2017-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c92a3f17e91bf3b293b96e434829d1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93c9c063f6216cf0ee17eb169877b058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20562ade05550e0886cc43139cdd7b54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_859222b027ebfff8ffe3e69247ed2f30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad5b0dc69eddf5c2229b4a1f86171e06
publicationDate 2017-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107412192-A
titleOfInvention A kind of preparation method and application of the nanometer formulation of Legumain responses substep release adriamycin/curcumin sustained release
abstract A kind of preparation method and application of the nanometer formulation of Legumain responses substep release adriamycin/curcumin sustained release, with the high expression Legumain of tumor tissues biological characteristics, the nanogel of Legumain responses is prepared, so as to realize the dual-target effect to tumor tissues(Active targeting and passive target)Reduce the secondary injury of adriamycin normal tissue, nanometer formulation prepared by the present invention can make medicine and inhibitor priority release function, into after cell, inhibitor first discharges from carrier, occupies drug-resistant protein avtive spot, then make insoluble drug release, it thus can at utmost reduce drug efflux, reverse multidrug resistance.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108210932-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108210932-B
priorityDate 2017-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412232924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450281383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID34367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415812460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9886157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414804309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6842
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6971205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415843556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6422
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393628
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450024817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430895435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21922555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454582935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92000569

Total number of triples: 81.